Author's posts
Bionpharma recalls pneumonia medication
Bionpharma is recalling a batch of pneumonia drug Atovaquone Oral Suspension after it was found to be contaminated with Cohnella bacteria.
Ohio hospital COO steps down
Bernie Albertini stepped down from his role as administrator and chief operating officer of East Ohio Regional Hospital in Martins Ferry, effective Sept. 16.
$25M gift to fund Michigan Medicine breast cancer center
Ann Arbor-based Michigan Medicine will establish the Weiser Family Center for Breast Cancer after receiving a $25 million gift from the Weiser Charitable Foundation.
Healthcare leads in signing bonus offers
Healthcare tops the list of industries offering signing bonuses, according to Indeed job listings, The Wall Street Journal reported Sept. 19.
UC Riverside med school to create curriculum on substance use care
Researchers at the University of California Riverside School of Medicine are developing a curriculum to educate future physicians on caring for patients with substance use disorders.
Kaleida Health chief administrative officer to step down
Michael Hughes, senior vice president and chief administrative officer of Buffalo, N.Y.-based Kaleida Health, will depart the organization at the end of year.
Erlanger Foundation chief development officer to retire
Julie Taylor, president and chief development officer of Erlanger Health System’s philanthropic arm, will retire on September 30, according to a news release from the Chattanooga, Tenn.-based health system.
Clearing a path for diverse leadership
Creating a diverse nurse workforce and leadership team takes intentionality.
4 viruses-linked cancers that could become rare
Infections account for an estimated 13% of all cancer cases globally, the American Association for Cancer Research found, but more work is needed to help patients prevent these infections, The New York Times reported Sept. 18.
Cleveland Clinic trial shows promise in treating bleeding disorder
A phase 2 clinical trial has demonstrated that pomalidomide, used to treat bone marrow cancer, is safe and effective for managing hereditary hemorrhagic telangiectasia, a rare genetic bleeding disorder. The results were published Sept. 18 in the New En…
